Method of increasing immunological effect
A method of increasing immunological effect in a patient by administering an effective amount of a primary cell derived biologic to the patient, inducing immune production, blocking immune destruction, and increasing immunological effect in the patient. Methods of treating an immune target, treating a tumor, immune prophylaxis, and preventing tumor escape.
1. In a method of cytoprotective cancer therapy, the improvement comprising ex-vivo pre-incubation of T cells from a patient with an effective amount of a primary cell derived biologic, prior to administering said T cells to the patient.
2. The method of claim 1 wherein the primary cell derived biologic comprises interleukin 1beta (IL-1beta), interleukin 2(IL-2), interleukin 6 (IL-6), interleukin 8 (IL-8), tumor necrosis factor alpha (TNF-alpha), and interferon-gamma (IFN-gamma).
3. The method of claim 1 , wherein the T cells are primary blood-derived T cells from the patient.
4. The method of claim 3 , wherein the T cells comprise CD4 positive T cells.
5. The method of claim 3 , wherein the T cells comprise CD8 positive T cells.